Carol A. Nacy

8.1k total citations · 1 hit paper
116 papers, 6.7k citations indexed

About

Carol A. Nacy is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Carol A. Nacy has authored 116 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 33 papers in Epidemiology and 30 papers in Infectious Diseases. Recurrent topics in Carol A. Nacy's work include Research on Leishmaniasis Studies (41 papers), Tuberculosis Research and Epidemiology (24 papers) and Mycobacterium research and diagnosis (15 papers). Carol A. Nacy is often cited by papers focused on Research on Leishmaniasis Studies (41 papers), Tuberculosis Research and Epidemiology (24 papers) and Mycobacterium research and diagnosis (15 papers). Carol A. Nacy collaborates with scholars based in United States, Canada and Russia. Carol A. Nacy's co-authors include Monte S. Meltzer, Shawn J. Green, A H Fortier, Leo Einck, R. M. M. Crawford, John B. Hibbs, Marina Protopopova, Miodrag Belosevic, B. V. Nikonenko and D S Finbloom and has published in prestigious journals such as The Journal of Immunology, Journal of Clinical Microbiology and Journal of Medicinal Chemistry.

In The Last Decade

Carol A. Nacy

115 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.

1990 597 citations Shawn J. Green, Monte S. Meltzer et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Carol A. Nacy

Since Specialization

Citations

This map shows the geographic impact of Carol A. Nacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Nacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Nacy more than expected).

Fields of papers citing papers by Carol A. Nacy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Nacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Nacy. The network helps show where Carol A. Nacy may publish in the future.

Co-authorship network of co-authors of Carol A. Nacy

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Nacy. A scholar is included among the top collaborators of Carol A. Nacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Nacy. Carol A. Nacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits 2021 ·Antimicrobial Agents and Chemotherapy ·Oluwaseun Francis Egbelowo, Jansy P. Sarathy, (unknown), Matthew Zimmerman, Han Wang, (unknown), Firat Kaya, Martin Gengenbacher, (unknown), (unknown), Carol A. Nacy, Bree B. Aldridge, Claire L. Carter, Paolo Denti, Véronique Dartois	17
2	Tuberculosis — drugs in the 2016 development pipeline 2017 ·Nature Reviews Disease Primers ·Barbara E. Laughon, Carol A. Nacy	14
3	In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria 2010 ·Journal of Antimicrobial Chemotherapy ·(unknown), Elena Bogatcheva, Manju Yasoda Krishnan, Michael Collins, Leo Einck, Carol A. Nacy, Venkata M. Reddy	32
4	Discovery of dipiperidines as new antitubercular agents 2009 ·Bioorganic & Medicinal Chemistry Letters ·Elena Bogatcheva, Colleen F. Hanrahan, Ping Chen, Jacqueline Gearhart, Katherine A. Sacksteder, Leo Einck, Carol A. Nacy, Marina Protopopova	30
5	Drug Therapy of Experimental Tuberculosis (TB): Improved Outcome by Combining SQ109, a New Diamine Antibiotic, with Existing TB Drugs 2007 ·Antimicrobial Agents and Chemotherapy ·B. V. Nikonenko, Marina Protopopova, (unknown), Leo Einck, Carol A. Nacy	111
6	In Search of New Cures for Tuberculosis 2007 ·Medicinal Chemistry ·Marina Protopopova, Elena Bogatcheva, B. V. Nikonenko, (unknown), Leo Einck, Carol A. Nacy	43
7	Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis 2005 ·Protein Expression and Purification ·Brian V. Geisbrecht, B. V. Nikonenko, (unknown), Reiko Nakamura, Carol A. Nacy, Katherine A. Sacksteder	9
8	Interaction of anti-cholesterol antibodies with human lipoproteins 1996 ·The Journal of Immunology ·J.W. Dijkstra, Glenn M. Swartz, (unknown), (unknown), (unknown), Carol A. Nacy, Shawn J. Green	28
9	Liposomal Vaccines 1995 ·Advances in experimental medicine and biology ·Shawn J. Green, A H Fortier, J.W. Dijkstra, John W. Madsen, Glenn M. Swartz, Leo Einck, (unknown), Carol A. Nacy	6
10	Passive Protection of Mice Against Lethal Francisella Tularensis (Live Tularemia Vaccine Strain) Infection by the Sera of Human Recipients of the Live Tularemia Vaccine 1994 ·The American Journal of the Medical Sciences ·Joseph J. Drabick, R.B. Narayanan, (unknown), James W. LeDuc, Carol A. Nacy	59
11	IFN-γ produced in vivo during the first two days is critical for resolution of murine Leishmania major infections 1993 ·Microbial Pathogenesis ·David A. Leiby, Robert D. Schreiber, Carol A. Nacy	10
12	T-cell-independent resistance to infection and generation of immunity to Francisella tularensis 1993 ·Infection and Immunity ·Karen L. Elkins, Tonya R. Rhinehart-Jones, Carol A. Nacy, Robert K. Winegar, A H Fortier	73
13	Interleukin-2 and the Regulation of Activated Macrophage Cytotoxic Activities 1992 ·Advances in experimental medicine and biology ·Barbara J. Nelson, Miodrag Belosevic, Shawn J. Green, Jim A. Turpin, Carol A. Nacy	4
14	Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity 1992 ·Microbial Pathogenesis ·Karen L. Elkins, Robert K. Winegar, Carol A. Nacy, A H Fortier	41
15	Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities 1991 ·Research in Immunology ·Carol A. Nacy, Barbara J. Nelson, Monte S. Meltzer, Shawn J. Green	16
16	Cellular mechanisms of nonspecific immunity to intracellular infection: Cytokine-induced synthesis of toxic nitrogen oxides from l-arginine by macrophages and hepatocytes 1990 ·Immunology Letters ·Shawn J. Green, S Mellouk, Stephen L. Hoffman, Monte S. Meltzer, Carol A. Nacy	160
17	Interleukin-2, anti-interleukin-2 receptor antibody, and activation of macrophages 1990 ·Cellular Immunology ·Miodrag Belosevic, Carol A. Nacy	5
18	Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. 1988 ·The Journal of Immunology ·Miodrag Belosevic, Charles E. Davis, Monte S. Meltzer, Carol A. Nacy	131
19	Lymphokine Regulation of Macrophage Effector Activities 1988 ·Advances in experimental medicine and biology ·Carol A. Nacy, Miodrag Belosevic, R. M. M. Crawford, (unknown), Robert D. Schreiber, (unknown)	6
20	Macrophage activation for microbicidal activity against Leishmania major : inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. 1985 ·The Journal of Immunology ·(unknown), Carol A. Nacy, David L. Hoover, (unknown), Glenn M. Swartz, Monte S. Meltzer	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact